 <h1>Azilsartan medoxomil / chlorthalidone Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to azilsartan medoxomil/chlorthalidone: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Discontinue use of azilsartan medoxomil / chlorthalidone as quickly as possible if pregnancy is detected, as drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, azilsartan medoxomil / chlorthalidone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking azilsartan medoxomil / chlorthalidone:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>convulsions</li>
<li>decreased urine</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>fainting</li>
<li>increased thirst</li>
<li>irregular heartbeat</li>
<li>loss of appetite</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>shortness of breath</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Ankle, knee, or great toe joint pain</li>
<li>joint stiffness or swelling</li>
<li>lower back, side, or stomach pain</li>
<li>swelling of the feet or lower legs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of azilsartan medoxomil / chlorthalidone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Dizziness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Cough</li>
<li>diarrhea</li>
<li>lack or loss of strength</li>
<li>muscle spasm</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Headache</li>
<li>loss of appetite</li>
<li>rash</li>
<li>stomach cramps</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to azilsartan medoxomil / chlorthalidone: oral tablet</i></p><h3>General</h3><p>The most common side effects were dizziness and fatigue.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope</p>
<p><b>Postmarketing reports</b>: Loss of consciousness</p>
<p></p>
<p>Azilsartan:</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Frequency not reported</b>: Dizziness postural</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Frequency not reported</b>: Headache<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p></p>
<p>Azilsartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Fatigue</p>
<p><b>Frequency not reported</b>: Asthenia</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal</p>
<p></p>
<p>Azilsartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Uncommon</b> (0.1% to 1%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Postmarketing reports</b>: Nausea</p>
<p></p>
<p>Azilsartan:</p>
<p><b>Frequency not reported</b>: Diarrhea, nausea</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Frequency not reported</b>: Gastrointestinal upset<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Rash, pruritus, angioedema</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Chlorthalidone:</p>
<p><b>Frequency not reported</b>: Cholesterol elevated<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: BUN increased</p>
<p></p>
<p>Chlorthalidone:</p>
<p><b>Frequency not reported</b>: Uric acid elevated<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Azilsartan:</p>
<p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Azilsartan:</p>
<p><b>Frequency not reported</b>: Cough<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Edarbyclor (azilsartan-chlorthalidone)." Takeda Pharmaceuticals America, Lincolnshire, IL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about azilsartan medoxomil / chlorthalidone</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>19 Reviews</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Azilsartan and chlorthalidone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Edarbyclor</dd></dl>
<h3>Professional resources</h3>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to azilsartan medoxomil / chlorthalidone: oral tablet</i></p><h3>General</h3><p>The most common side effects were dizziness and fatigue.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Syncope</p><p><b>Postmarketing reports</b>: Loss of consciousness</p><p></p><p>Azilsartan:</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Frequency not reported</b>: Dizziness postural</p><p></p><p>Chlorthalidone:</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Frequency not reported</b>: Headache<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p></p><p>Azilsartan:</p><p><b>Uncommon</b> (0.1% to 1%): Fatigue</p><p><b>Frequency not reported</b>: Asthenia</p><p></p><p>Chlorthalidone:</p><p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal</p><p></p><p>Azilsartan:</p><p><b>Uncommon</b> (0.1% to 1%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal</p><p></p><p>Chlorthalidone:</p><p><b>Uncommon</b> (0.1% to 1%): Consecutive creatinine increases of 50% or greater from baseline and greater than the upper limit of normal<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Postmarketing reports</b>: Nausea</p><p></p><p>Azilsartan:</p><p><b>Frequency not reported</b>: Diarrhea, nausea</p><p></p><p>Chlorthalidone:</p><p><b>Frequency not reported</b>: Gastrointestinal upset<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Rash, pruritus, angioedema</p><p></p><p>Chlorthalidone:</p><p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Chlorthalidone:</p><p><b>Frequency not reported</b>: Cholesterol elevated<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: BUN increased</p><p></p><p>Chlorthalidone:</p><p><b>Frequency not reported</b>: Uric acid elevated<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Azilsartan:</p><p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Azilsartan:</p><p><b>Frequency not reported</b>: Cough<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Edarbyclor (azilsartan-chlorthalidone)." Takeda Pharmaceuticals America, Lincolnshire, IL. </p><h2>More about azilsartan medoxomil / chlorthalidone</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>19 Reviews</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Azilsartan and chlorthalidone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>